EUVIMEDEUVIMED entdecken
Crossref

Welcoming the Era of Gene Editing in Medicine

George Q Daley

New England Journal of Medicine · 2024

DOI: 10.1056/nejmp2314279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von George Q Daley. Beteiligte Einrichtung: From Boston Children's Hospital and Harvard Medical School - both in Boston. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, CRISPR-Cas Systems, Gene Editing, Genetic Therapy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But ensuring access will be challenging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellCRISPR-Cas SystemsGene EditingGenetic TherapyHumansFetal HemoglobinGenetic Diseases, InbornHematologic Agents

Substanzen

Fetal HemoglobinHematologic Agents

Autor:innen und Institutionen

  • From Boston Children's Hospital and Harvard Medical School - both in Boston.

Zitieren

APA

Daley, G. Q. (2024). Welcoming the Era of Gene Editing in Medicine. New England Journal of Medicine. https://doi.org/10.1056/nejmp2314279

Vancouver

Daley GQ. Welcoming the Era of Gene Editing in Medicine. New England Journal of Medicine. 2024. doi:10.1056/nejmp2314279

BibTeX
@article{Daley2024,
  author = {Daley, George Q},
  title = {Welcoming the Era of Gene Editing in Medicine},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmp2314279}
}
Kostenlos starten →